You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AstraZeneca
since
auto-detected in 70 stories
14 days ago
For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.
16 days ago
AstraZeneca stock dives 9% after heart drug trial misses target ⊖
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
38 days ago
Widow of NHS pharmacist who took his own life when he was denied compensation after Covid jab left him paralysed wins years-long fight for payout ⊖
found
a story from The Daily Mail 💩 › The Daily Mail
John Cross suffered a rare reaction to the AstraZeneca jab which left him in hospital on a ventilator, unable to move, talk or breathe.
46 days ago
AstraZeneca advances weight-loss pill to take aim at obesity leaders ○
found
a story from Financial Times ✅ › Financial Times
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
49 days ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success ⊕⊕
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
85 days ago
AstraZeneca stock falls after FDA panel votes against new cancer drug ⊖
The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
87 days ago
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies ⊕⊕
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
3 months ago
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed ⊕
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
5 months ago
AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment ⊕
found
a story from The Guardian ⚠️ › International
Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site
Business live – latest updates
The boss of Britain’s biggest pharmaceutical company has said the govern…
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation ⊕
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.